Skip to main content
. Author manuscript; available in PMC: 2020 Nov 30.
Published in final edited form as: Surg Oncol Clin N Am. 2020 Apr;29(2):145–163. doi: 10.1016/j.soc.2019.11.002

Fig. 5.

Fig. 5.

Targeted molecular imaging and therapy (PRRT) and theranostics concept. Theranostics is the use of diagnostic radionuclides (68Cu, 68Ga) and therapeutic radionuclides (90Y, 177Lu, 212Pb) labeled to the same somatostatin congener (TOC or TATE).90 (Courtesy of H. Maecke, University Hospital, Basel, CH.)